I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Camrelizumab Combined With Apatinib Mesylate for Head and Neck Squamous Cell Carcinoma
This is a prospective, open-labelled study to evaluate the efficacy and safety of camrelizumab combined with apatinib mesylate in the induction treatment of patients with locally advanced head and neck squamous cell carcinoma who were judged surgically unresectable or appropriate for non-surgical definitive therapy. The objective response rate (ORR) and …
measurable disease
caries
squamous cell carcinoma of head and neck
advanced head and neck squamous cell carcinoma
squamous cell carcinoma
- 0 views
- 19 Feb, 2024